News for Pfizer Stock (PFE)

Pfizer COVID vaccine is safe and effective for children 5 to 11 years old, company says

CNET • 09/20/21

Pfizer/BioNTech COVID-19 Vaccine Data For Kids Is Here: What You Need To Know

Benzinga • 09/20/21

Pfizer and BioNTech to seek approval to vaccinate children after Covid study

Proactive Investors • 09/20/21

Pfizer says COVID-19 vaccine safe and effective for children as young as five

Market Watch • 09/20/21

Pfizer Prepares To Seek U.S., EU Approval For Its Covid Vaccine In Kids As Young As Five

Forbes • 09/20/21

Pfizer says its Covid vaccine is safe and generates robust immune response in kids ages 5 to 11

CNBC • 09/20/21

Pfizer and BioNTech Announce Positive Topline Results From Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years

Business Wire • 09/20/21

Pfizer says its COVID-19 vaccine is safe and likely to work in younger children, and it's planning to ask for permission to use it in kids as young as 5

Business Insider • 09/20/21

Pfizer COVID vaccine trial for children aged under 12 shows 'robust immune response'

Skynews • 09/20/21

Could Pfizer and Merck Be Big Winners With COVID Pills?

The Motley Fool • 09/19/21

FDA Advisory Committee Votes Unanimously in Favor Of COMIRNATY® Booster for Emergency Use in People 65 and Older and Certain High-risk Populations

Business Wire • 09/17/21

Astellas' and Pfizer's XTANDI® (enzalutamide) Reduced Risk of Death by 34% in Men with Metastatic Hormone-Sensitive Prostate Cancer in Phase 3 ARCHES Study

PRNewsWire • 09/17/21

Influential FDA Panel Votes Down Widespread Pfizer Booster; Approves Third Shot For 65 & Older + Those At “High Risk”

Deadline • 09/17/21

FDA panel votes to recommend third shot for some Pfizer vaccine recipients

CNET • 09/17/21

FDA Panel Votes Against Approval Of Pfizer/BioNTech's COVID-19 Booster Shot For General Public

Benzinga • 09/17/21

FDA panel votes against Pfizer booster for general public

CNET • 09/17/21

FDA Advisory Panel Recommends Against Pfizer Covid Boosters—Except For People Over 65

Forbes • 09/17/21

FDA committee votes against approving BioNTech and Pfizer's COVID-19 booster

Market Watch • 09/17/21

FDA panel rejects plan to administer Pfizer's Covid booster doses to general public

CNBC • 09/17/21

FDA's Vaccine Advisory Committee Weighs Necessity Of Pfizer Covid Booster Shots

Forbes • 09/17/21

Pfizer, Moderna Support COVID Vaccine Booster Before FDA Meet

Zacks Investment Research • 09/16/21

2 Pharma Stocks You Can Buy and Hold for the Next Decade

The Motley Fool • 09/16/21

Here's Why Pfizer Stock Can Rebound After Falling Nearly 15% From Its Peak Last Month

Forbes • 09/16/21

Should Pfizer Investors Worry About Tomorrow's FDA Meeting?

The Motley Fool • 09/16/21

Pfizer Inc. (PFE) Management Presents on Bank of America Global Healthcare Conference (Transcript)

Seeking Alpha • 09/15/21